China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Initial Therapy with Glucocorticoids plus Obinutuzumab for Pediatric Steroid-Sensitive Nephrotic Syndrome'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130159
Registration Time: 2026/08/17
Type: Observational study
Primary Sponsor: Capital Medical University Affiliated Capital Institute of Pediatrics
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325552
Published by HT Digital Content Services with permission from Health Daily Digest....